{"id":11726,"date":"2018-10-12T10:05:37","date_gmt":"2018-10-12T14:05:37","guid":{"rendered":"https:\/\/medicarereport.org\/?p=11726"},"modified":"2018-10-12T10:05:37","modified_gmt":"2018-10-12T14:05:37","slug":"the-2019-medicare-plans-with-5-stars","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=11726","title":{"rendered":"The 2019 Medicare plans with 5 stars"},"content":{"rendered":"<p>(By Morgan Haefner for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n<p>CMS\u00a0<a href=\"https:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovGenIn\/PerformanceData.html\" target=\"_blank\" rel=\"noopener noreferrer\">released<\/a>\u00a0its report card for Medicare Advantage and Part D prescription drug plans Oct. 10.<\/p>\n<p>Medicare ranks Medicare Advantage and Part D plans on a quality scale of one to five stars, with five representing excellent performance and one reflecting poor performance. CMS also pays bonuses to plans with high ratings. <a href=\"https:\/\/www.beckershospitalreview.com\/payer-issues\/the-2019-medicare-plans-with-5-stars.html\">Continue reading article here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/CMS-logo.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-7780\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/CMS-logo-300x105.jpg\" alt=\"\" width=\"300\" height=\"105\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/CMS-logo-300x105.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/CMS-logo.jpg 382w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Morgan Haefner for Becker&#8217;s Hospital Review) CMS\u00a0released\u00a0its report card for Medicare Advantage and Part D prescription drug plans Oct.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32,9,15],"tags":[],"class_list":["post-11726","post","type-post","status-publish","format-standard","hentry","category-cms","category-medicare-advantage","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11726"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11726\/revisions"}],"predecessor-version":[{"id":11727,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11726\/revisions\/11727"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}